232 related articles for article (PubMed ID: 9458437)
1. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
Wang A; Bashore TM
Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437
[No Abstract] [Full Text] [Related]
2. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
3. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
5. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
[No Abstract] [Full Text] [Related]
6. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
[No Abstract] [Full Text] [Related]
7. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
Mikhail G; Gibbs J; Richardson M; Wright G; Khaghani A; Banner N; Yacoub M
Eur Heart J; 1997 Sep; 18(9):1499-504. PubMed ID: 9458458
[TBL] [Abstract][Full Text] [Related]
8. [Rebound effect after prostacyclin inhalation in pulmonary hypertension].
Moro JA; Almenar L; Morales P; Osa A
Med Clin (Barc); 2007 Jul; 129(7):279. PubMed ID: 17683713
[No Abstract] [Full Text] [Related]
9. [Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension].
Osvaldo Cáneva J; Ossés JM
Medicina (B Aires); 2003; 63(3):233-6. PubMed ID: 12876911
[TBL] [Abstract][Full Text] [Related]
10. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Barry PW
Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434
[No Abstract] [Full Text] [Related]
11. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Matthes J; Mathen F; Herzig S; Wassermann K
Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
[No Abstract] [Full Text] [Related]
12. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Tibballs J; Goh TH; McKenzie I; Hochmann M
Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
[No Abstract] [Full Text] [Related]
13. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH
J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
15. Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia.
Kinugasa H; Horigome H; Sugiura M; Saito T; Iijima T; Matsui A
Pediatr Int; 2002 Oct; 44(5):525-7. PubMed ID: 12225554
[No Abstract] [Full Text] [Related]
16. Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report.
Hashida H; Hamada M; Shigematsu Y; Ikeda S; Kuwahara T; Kawakami H; Hara Y; Kodama K; Kohara K; Hiwada K
Angiology; 1998 Feb; 49(2):161-4. PubMed ID: 9482517
[TBL] [Abstract][Full Text] [Related]
17. Ventilation/perfusion ratios in pulmonary arterial hypertension: effects of IV and inhaled prostacyclin derivatives.
Bratel T; Lagerstrand L; Brodin LA; Nowak J; Randmaa I
Chest; 2005 Dec; 128(6 Suppl):615S-616S. PubMed ID: 16373868
[No Abstract] [Full Text] [Related]
18. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).
Humbert M; Sanchez O; Fartoukh M; Jagot JL; Sitbon O; Simonneau G
Chest; 1998 Jul; 114(1 Suppl):80S-82S. PubMed ID: 9676646
[No Abstract] [Full Text] [Related]
19. Successful epoprostenol withdrawal in pulmonary arterial hypertension: case report and literature review.
Demerouti EA; Manginas AN; Athanassopoulos GD; Karatasakis GT; Leontiadis ED; Pavlides GS
Respir Care; 2013 Feb; 58(2):e1-5. PubMed ID: 22710078
[TBL] [Abstract][Full Text] [Related]
20. Treatment of primary pulmonary hypertension.
Handa S
Intern Med; 2002 Oct; 41(10):757-8. PubMed ID: 12412989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
